文献速递肝病

肝豆状核变性患者的妊娠:管理与结局

Pregnancy in Wilson's disease: Management and outcome.
PubMed 文献 · Hepatology · 2018-02-18

这项回顾性多中心研究分析了136例肝豆状核变性(WD)患者的282次妊娠,发现妊娠期间肝功能检查恶化见于16/282(6%)次妊娠且产后均恢复,自发性流产率为73/282(26%),已诊断并接受治疗者自发性流产显著少于未诊断者(比值比2.853,95%CI 1.634-4.982),出生缺陷见于7/209(3%)活产。结论认为接受驱铜治疗的WD患者妊娠是安全的。

要点

  • 妊娠期间肝功能检查恶化见于16/282(6%)次妊娠,产后均恢复。
  • 已诊断并治疗者自发性流产显著少于未诊断者(比值比2.853,95%CI 1.634-4.982)。
  • 出生缺陷见于7/209(3%)活产,妊娠期间应维持WD治疗并密切监测肝和神经症状。

核心结论

  • 接受驱铜治疗的WD患者妊娠是安全的。
  • 接受治疗者的自发性流产率低于未治疗者。
  • 尽管铜螯合剂有致畸担忧,本队列出生缺陷率低。
  • 妊娠期间应维持WD治疗,并密切监测肝和神经症状。

研究设计与样本

  • 回顾性多中心研究,纳入136例WD患者的282次妊娠。
  • 记录发病年龄、受孕年龄及WD特异性治疗。
  • 分析妊娠期母体并发症、自发性流产率及出生缺陷与妊娠期药物治疗的关系。

主要发现

  • 肝功能检查恶化见于16/282(6%)次妊娠,发生于未诊断及正在治疗的患者,产后均恢复。
  • 妊娠期间神经症状加重罕见(1%),但倾向于产后持续。
  • 研究队列总自发性流产率为73/282(26%)。
  • 已诊断并接受药物治疗的WD患者自发性流产显著少于未诊断WD患者(比值比2.853,95%CI 1.634-4.982)。
  • 出生缺陷见于7/209(3%)活产。

临床怎么用

  • 妊娠期间应维持WD治疗,并密切监测肝和神经症状。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Wilson's disease (WD) is a rare inherited disorder of copper metabolism causing toxic hepatic and neural copper accumulation. Clinical symptoms vary widely, from asymptomatic disease to acute liver failure or chronic liver disease with or without neuropsychiatric symptoms. Continuation of specific medical treatment for WD is recommended during pregnancy, but reports of pregnancy outcomes in WD patients are sparse. In a retrospective, multicenter study, 282 pregnancies in 136 WD patients were reviewed. Age at disease onset, age at conception, and WD-specific treatments were recorded. Maternal complications during pregnancy, rate of spontaneous abortions, and birth defects were analyzed with respect to medical treatment during pregnancy. Worsening of liver function tests was evident during 16 of 282 (6%) pregnancies and occurred in undiagnosed patients as well as in those under medical treatment. Liver test abnormalities resolved in all cases after delivery. Aggravation of neurological symptoms during pregnancy was rare (1%), but tended to persist after delivery. The overall spontaneous abortion rate in the study cohort was 73 of 282 (26%). Patients with an established diagnosis of WD receiving medical treatment experienced significantly fewer spontaneous abortions than patients with undiagnosed WD (odds ratio, 2.853 [95% confidence interval, 1.634-4.982]). Birth defects occurred in 7 of 209 (3%) live births. CONCLUSION: Pregnancy in WD patients on anticopper therapy is safe. The spontaneous abortion rate in treated patients was lower than that in therapy-naïve patients. Although the teratogenic potential of copper chelators is a concern, the rate of birth defects in our cohort was low. Treatment for WD should be maintained during pregnancy, and patients should be monitored closely for hepatic and neurological symptoms. (Hepatology 2018;67:1261-1269).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Pfeiffenberger J, Beinhardt S, Gotthardt DN, et al. Pregnancy in Wilson's disease: Management and outcome. Hepatology. 2018. PMID: 28859232. doi:10.1002/hep.29490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。